Preoperative Use of Montelukast Sodium

• Status: Completed
• Trial end date: 2015-06-01
• Target enrollment: 0
• Participant gender: All

Summary

Supraglottic airway equipment used during anaesthesia application can lead to airway reactivity or even larynx spasm in sensitive children.

Montelukast Sodium, used in asthma treatment, is a cysteinyl leukotriene Type 1 antagonist which reduces leukotriene C4, leukotriene D4 and leukotriene E4 synthesis. The use of Montelukast Sodium in airway reactivity is known to reduce the need for bronchodilator and corticosteroids.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Umraniye Education and Research Hospital
• Treatments: Montelukast

Criteria

Inclusion Criteria:

• Patients undergoing inguinal hernia surgery

Exclusion Criteria:

• If receiving asthma treatment,

• If they had URTI in the last week and

• If LMA could not be placed at a single attempt.